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1. INTRODUCTION 
It has been reported that peritoneal injection of 
cortisone stimulates nucleolar RNA polymerase I
activity but not nucleoplasmic RNA polymerase 
activity in rat liver [1,2]. Later, injection of corti- 
sone acetate was reported to stimulate both free 
and chromatin-bound RNA polymerase I activities 
through rapid protein turnover [3], consistent with 
[4,5]. Both forms of RNA polymerase II activities 
remained unchanged by this treatment [3]. How- 
ever, in [6] free RNA polymerase II activity was re- 
ported to be drastically increased (2.5-3.5fold of 
control activity) and template-engaged enzyme 
activity was considerably decreased after cortisone 
injection. 
as in [7] with only slight modification. Five male 
Sprague-Dawley rats (-150 g body wt) were sacri- 
ficed at 1.5 h after intraperitoneal injection of 
5 mg cortisone acetate (Fluka). Five control ani- 
mals were injected with saline. All the following 
steps were performed at 4°C. The liver was minced 
with scissors and homogenized in 2 vol. 2.1 M suc- 
rose containing 3 mM MgCl* with 12 strokes in a 
Potter homogenizer. After filtration of the homo- 
genate through 4 layers of gauze, 8 vol. of the same 
solution was added and mixed. The nuclear pellet 
was obtained by centrifugation at 28000 rev./min 
for 60 min in a Hitachi RP-30 rotor. 
2.2. Differential solubilization of free and chro- 
matin-bound RNA polymerase in nuclei 
To compare directly the finding in [3] with that 
in [6], the early effect of cortisone on free and 
chromatin-bound RNA polymerase II activities 
was analyzed under the same conditions as those 
used in [6]. Here, evidence is presented that solu- 
bilized free and bound RNA polymerase I activities 
were stimulated at 1.5 h after cortisone treatment, 
while both forms of RNA polymerase II activity re- 
mained unchanged. Reasons for the discrepancy 
between these results and those in [6] will be discus- 
sed by pointing out assay problems of free and 
template-engaged RNA polymerases. 
2. MATERIALS AND METHODS 
2.1. Cortisone treatment and isolation of nuclei 
Isolation of nuclei from rat liver was performed 
Free RNA polymerase was prepared by a slight 
modification of the method in [8]. Nuclei were sus- 
pended in 2 ml 0.34 M sucrose/g wet wt liver and 
homogenized by hand in a Potter homogenizer. 
The homogenate was cenrifuged at 1000 x g for 10 
min; and the pellet was resuspended in the same 
volume of 0.34 M sucrose and recentrifuged at 
1000 x g for 10 min. The supernatants were com- 
bined, salted out by the addition of 2 vol. saturated 
(NH&SO4 (pH 7.9), and centrifuged at 16000 
rev./min for 15 min in a Beckman JA-20 rotor. 
The pellet was dissolved in 2 ml TGMED buffer 
(50 mM Tris-HCI (pH 7.9), 20% glycerol, 5 mM 
MgCl,, 0.1 mM EDTA and 0.1 mM dithiothreitol). 
Chromatin-bound enzyme activity was assayed in a 
pelleted fraction from nuclei prepared by the soni- 
cation method in [9]. Both free and bound enzyme 
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preparations were dialyzed against TGMED buffer 
containing 40 mM (NH&SO,. 
2.3. DEAE-Sephadex A-25 chromatography of 
RNA polymerases 
The crude preparations of free or bound RNA 
polymerase were applied to a DEAE-Sephadex A-25 
column (1.8 x 15 cm) equilibrated with TGMED 
buffer containing 40 mM (NH&SO4 and eluted 
with TGMED buffer containing a linear gradient 
of from 40-400 mM (NH4)$04. For the assay of 
enzyme activity, 0.1 ml of each column fraction 
was used. 
2.4. Assay for RNA polymerase activity 
RNA polymerase activity was determined as in 
[lo]. Furthermore, total RNA polymerase activity 
in whole nuclei was measured by using a nuclear 
suspension in 0.34 M sucrose (70 pg DNA/assay 
mixture). The activity of free RNA polymerase in 
whole nuclei was assayed using poly(dA-dT) (6.25 
AZ&ml) as template. The DNA content of nuclei 
was determined as in [ 111. 
3. RESULTS AND DISCUSSION 
Free and chromatin-bound RNA polymerase II 
activities and the ratio of the enzyme activities were 
not changed at 1.5 h after the cortisone treatment 
(table I). This result is different from that in [6] 
where free RNA polymerase II activity was drastic- 
ally increased (2.5-fold of control activity) and the 
Table 1 
Free and chromatin-bound RNA polymerase II activity 
[3H]UMP Incorporation (cpm/g liver) 
Form Control + Cortisone + Cortisone 
control 
Free 12202 + 625 11836 + 506 0.97 
(2.51) 
Bound 32745 t 448 33 169 + 619 1.01 
(0.91) 
Free/bound 0.37 0.36 
(0.54) (1.50) 
Each reported activity represents the mean and standard 
error of 5 animals. The value in parentheses is that 
from [6] 
42 
(a) 
Fig. 1. DEAE-Sephadex A-25 column chromatography 
of free and chromatin-bound RNA polymerases from 
control and cortisone-treated animals. The crude free (a) 
and chromatin-bound (b) preparations from control (0) 
and cortisone-treated (0) animals were chromato- 
graphed on Sephadex A-25 columns as in section 2. 
ratio of the enzyme activities was greatly altered. 
In order to confirm this finding, enzymes from 
control and cortisone-treated animals were puri- 
fied by DEAE-Sephadex A-25 chromatography. 
Although free and bound RNA polymerase I acti- 
vities were considerably increased, both RNA poly- 
merase II activities remained unchanged (fig. 1). 
This discrepancy seems to be derived from the 
technical problems involved in assaying the nuclear 
free and chromatin-bound (engaged) enzyme acti- 
vities. In [6] free enzyme activity was measured by 
the poly(dA-dT)-actinomycin D technique [5] and 
template-engaged enzyme activity by RNA poly- 
merizing activity of whole nuclei. The poly- 
(dA-dT) technique is based on the finding that 
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actinomycin D intercalates into G: C basepairs or 
between guanine and its neighbouring residues 
[121, allowing poly(dA-dT)-dependent enzyme 
activity to be assayed in the presence of actino- 
mycin D. However, this evaluation of free enzyme 
activity is not complete: 
(i) Natural DNA has a saturation level for the 
strong actinomycin D binding to G: C pairs or 
nucleotides around the guanosine [13]; 
(ii) Only 60% of G : C basepairs found in crab poly 
(dA-dT) - poly(dT-dA) are binding sites for 
actinomycin D [14]. 
Therefore, actinomycin D cannot mask endo- 
genous template completely. In fact, even very high 
concentrations of actinomycin D (> 400 pg/ml) 
cannot completely repress RNA polymerase II acti- 
vity; in our work considerable background enzyme 
activity remained (not shown). In addition, free en- 
zyme activity in the nuclear system detected by the 
poly(dA-dT) technique was strongly affected by 
the ionic strength of the assay system. The free en- 
zyme activity was apparently increased in the pre- 
sence of relatively low ionic strength. This over- 
estimation of free enzyme activity seems to be due 
to enzyme which was only loosely bound to 
chromatin and which utilized the poly(dA-dT) 
template [ 151. 
Furthermore, the engaged enzyme activity can- 
not be determined by the whole nuclear assay sys- 
tern 
(i) 
(ii) 
(iii) 
for the following reasons: 
This assay cannot discriminate chromatin 
template availability from the chromatin- 
bound enzyme itself. 
Endogenous template-dependent RNA synthe- 
sis in the whole nuclei assay system using < 100 
mM KC1 as in [6] represents not only tem- 
plate-engaged enzyme activity but also the re- 
initiation activity of free or loosely chromatin- 
bound enzymes [15]. 
There are various inhibitory and stimulatory 
factors affecting RNA synthesis in the crude 
nuclear system. 
The enzymes must be separated from these fac- 
tors by procedures such as differential enzyme 
solubilization or DEAE-Sephadex chromatogra- 
phy. RNA polymerase II activity/mg liver DNA 
determined by two methods are compared in table 
2. One set of activities was assayed using differen- 
tially solubilized enzymes, and the other deter- 
mined using whole nuclei. The results of these 
Table 2 
RNA polymerase II activities as measured by the solub- 
ilization or by the whole nuclear assay methods 
Form [3H]UMP incorporation (cpm/mg DNA) 
Free 
Bound 
Free/bound 
Solubilization Nuclear assay 
6720 11867 
14832 11046 
0.45 1.07 
Each value represents he average of triplicate assays 
methods differ considerably from each other, and 
the corresponding ratios of free and bound enzyme 
activities measured by the two techniques are vastly 
different. 
Therefore, the nuclear assay system in [6] might 
not correctly evaluate the activity of free and tem- 
plate-engaged RNA polymerase II. 
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